Newspaper publication as per regulation 47 of SEBI (LODR) 2015.
Appointment of Internal Auditor for the year 2026-27
Audited Financial Results for the Fourth Quarter and Financial year ended 31st March 2026
Financial Results for the Fourth Quarter and Financial Year ended 31st March 2026
Annual Secretarial Compliance Report for the year ended 31 March 2026
Hindustan Bio Sciences Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2026 ,inter alia, to consider and approve Intimation of Board Meeting under regulation 29 (1) (a) of SEBI (Listing Obligations and Disclosure requirements) regulations, 2015
We are hereby submitting the certificate issued by Venture Capital and Corporate Investments Private Limited in compliance with the Regulation 74(5) of SEBI(Depositories and Participants) Regulation, 2018 for the Fourth quarter and year ended on 31st March, 2026
The Trading window for the dealing in securities of the Company will remain closed from April 01, 2026 till 48 hours after the announcement of Standalone Audited Financial results for the year ending on March 31, 2026
We are hereby submitting the Newspaper Advertisement in Hitech Edition (English Language) and Prajapalana (Telugu Language) regarding Unaudited Standalone financial results for the Third Quarter ended on December 31, 2025
Un-audited results for quarter ended 31-12-2025
| Particulars | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue from Operations | 0.00 | 0.32 | 0.32 | 0.39 | 0.41 | 0.00 | 0.00 | 0.38 | 0.32 | 0.00 | 0.38 | 0.00 |
| YOY Revenue Growth % | -100% | - | 1.29% | 16.92% | - | -100% | -100% | -3.55% | -21.7% | - | - | -100% |
| Other Income | 0.00 | 0.01 | 0.01 | 0.00 | 0.01 | 0.00 | 0.00 | 0.01 | 0.01 | 0.01 | 0.02 | 0.00 |
| Total Income | 0.00 | 0.33 | 0.34 | 0.39 | 0.43 | 0.00 | 0.00 | 0.39 | 0.34 | 0.01 | 0.40 | 0.00 |
| Total Expenses + | 0.12 | 0.26 | 0.27 | 0.35 | 0.34 | 0.05 | 0.04 | 0.28 | 0.32 | 0.07 | 0.32 | 0.12 |
| Cost of Materials Consumed | 0.00 | 0.00 | 0.20 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Employee Benefit Expense | 0.05 | 0.04 | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 0.04 | 0.05 | 0.05 | 0.05 |
| Other Expenses | 0.07 | 0.02 | 0.03 | 0.08 | 0.06 | 0.02 | 0.01 | 0.01 | 0.06 | 0.01 | 0.02 | 0.06 |
| Operating Profit | -0.12 | 0.06 | 0.05 | 0.04 | 0.07 | -0.05 | -0.04 | 0.10 | 0.00 | -0.07 | 0.06 | -0.12 |
| OPM % | 0% | 17.8% | 16.9% | 10.5% | 16.4% | 0% | 0% | 25.4% | 0.2% | 0% | 16.8% | 0% |
| Profit Before Tax + | -0.12 | 0.07 | 0.07 | 0.04 | 0.08 | -0.05 | -0.04 | 0.11 | 0.01 | -0.06 | 0.08 | -0.12 |
| Tax Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Tax % | - | 0% | 0% | 0% | 0% | - | - | 0% | 0% | - | 0% | - |
| Profit After Tax | -0.12 | 0.07 | 0.07 | 0.04 | 0.08 | -0.05 | -0.04 | 0.11 | 0.01 | -0.06 | 0.08 | -0.12 |
| EPS (Basic) | -0.12 | 0.06 | 0.07 | 0.04 | 0.08 | -0.05 | -0.40 | 0.11 | 0.01 | -0.06 | 0.08 | -0.11 |
| Particulars | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
| Revenue from Operations | 0.74 | 0.81 | 1.03 | 0.92 | 0.44 | 1.03 |
| YOY Revenue Growth % | -9.37% | -20.95% | 11.55% | 111.29% | -57.7% | - |
| Other Income | 0.00 | 0.00 | 0.02 | 0.00 | 0.05 | 0.00 |
| Total Income | 0.74 | 0.81 | 1.05 | 0.92 | 0.49 | 1.03 |
| Total Expenses + | 0.82 | 0.72 | 1.00 | 0.96 | 1.00 | 1.99 |
| Employee Benefit Expense | 0.19 | 0.13 | 0.15 | 0.24 | 0.24 | 0.25 |
| Other Expenses | 0.15 | 0.09 | 0.20 | 0.14 | 0.47 | 1.05 |
| Operating Profit | -0.08 | 0.10 | 0.03 | -0.04 | -0.57 | -0.96 |
| OPM % | -10.8% | 12.1% | 2.9% | -4.1% | -129.9% | -92.6% |
| Profit Before Exceptional | -0.08 | 0.10 | 0.05 | -0.04 | -0.51 | -0.96 |
| Exceptional Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Profit Before Tax + | -0.08 | 0.10 | 0.05 | -0.04 | -0.51 | -0.96 |
| Tax Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -0.02 |
| Tax % | - | -2.6% | -8.1% | - | - | - |
| Profit After Tax | -0.08 | 0.10 | 0.06 | -0.04 | -0.52 | -0.94 |
| EPS (Basic) | -0.08 | 0.10 | 0.06 | -0.04 | -0.50 | -0.92 |
| Particulars | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
| ASSETS | ||||||
| Non-Current Assets + | 2.42 | 2.43 | 2.42 | 2.43 | 2.44 | 2.59 |
| Property, Plant & Equipment | 0.01 | 0.03 | 0.03 | 0.03 | 0.04 | 0.04 |
| Capital Work in Progress | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non-Current Investments | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Goodwill | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Intangible Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Current Assets + | 0.77 | 1.00 | 0.95 | 0.86 | 0.54 | 0.90 |
| Inventories | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Trade Receivables | 0.05 | 0.44 | 0.44 | 0.45 | 0.14 | 0.81 |
| Cash and Cash Equivalents | 0.13 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 |
| Current Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| LIABILITIES & EQUITY | ||||||
| Total Equity | 0.83 | 0.91 | 0.80 | 0.75 | 0.79 | 1.30 |
| Equity Share Capital | 2.05 | 2.05 | 2.05 | 2.05 | 10.25 | 10.25 |
| Other Equity | -1.22 | -1.15 | -1.25 | -1.30 | -9.46 | -8.95 |
| Non-Current Liabilities | 2.35 | 2.51 | 2.56 | 1.12 | 1.07 | 0.73 |
| Current Liabilities | 0.02 | 0.01 | 0.01 | 1.42 | 1.12 | 1.45 |
| Total Liabilities | 2.37 | 2.52 | 2.57 | 2.54 | 2.19 | 2.18 |
| Particulars | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
| Cash from Operating Activities | 0.28 | 0.03 | -0.08 | -0.29 | -0.31 | 0.75 |
| Cash from Investing Activities | -0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash from Financing Activities | -0.16 | -0.05 | 0.10 | 0.29 | 0.31 | -0.93 |
| Net Increase/Decrease in Cash | 0.12 | -0.02 | 0.03 | 0.00 | -0.01 | -0.18 |